The proteomic LC-MS strategy revealing autoimmune mechanisms with new clarity for clinical research

Integrated proteomics and multiomics strategies are transforming the way researchers investigate immune dysregulation and disease mechanisms. As autoimmune disorders continue to rise in prevalence and complexity, scientists require analytical approaches capable of capturing system‑wide biological interactions with both depth and precision.

In this SelectScience® webinar, council member of the Human Proteome Organization, Dr. Allan Stensballe, will explore how combining proteomics multiomics workflows can unlock deeper immunological insight in autoimmune disease research. Attendees will learn how LC‑MS‑based analysis of diverse biomolecules supports systems‑level investigation and translational studies, delivering high analytical depth with faster turnaround times compared to traditional analytical techniques.

Who should attend?

• Professionals in biopharmaceuticals
• Clinical research physicians
• Post doc students
• Biopharmaceutical contract research organizations (CROs)

Speaker: Dr. Allan Stensballe (Associate professor, Head of Laboratory for Precision Health, Aalborg University)

Dr. Allan Stensballe is a prominent figure in the fields of proteomics, systems biology, inflammation, biomarker discovery, and omics data analysis. He is current council member of the Human Proteome organization and the European Bioinformatics infrastructure ELIXIR.

Dr. Stensballe's expertise is deeply rooted in proteomics and the application of proteomics for understanding human disease pathology, especially in the context of precision health for autoimmune disorders. He has been pivotal in leading the precision health segment of the Laboratory for Precision health research group at Aalborg University in Denmark. This initiative aims to bridge the gap between academic research and small to medium-sized enterprises (SMEs) through technology-driven innovation, particularly in crucial areas that impact global health and wellness.

Moderator: Olivia Long (Editorial Team, SelectScience)

As a Science Editor specializing in pharmaceutical and applied research, Olivia Long brings a strong background in experimental biology and scientific communication. She holds a B.Sc. in Pharmacology from the University of Southampton and an M.Sc. in Neuroscience from the University of Sussex, where she investigated neuro‑oncology drug‑resistance pathways using patient‑derived cell models.

Her broader laboratory experience spans R&D hygiene testing, controlled environment entomology workflows, and protocol development, giving her a practical understanding of diverse analytical and research environments. She is dedicated to translating complex science into clear, engaging content for researchers and industry professionals.